Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to find out more about the effectiveness of Tadalafil in improving hemodynamic capabilities, endothelial function, and end-organ function in patients who have previously undergone a Fontan Palliation.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05206955
Study type Interventional
Source Mayo Clinic
Contact ACHD Research Team
Phone 507-293-2565
Status Recruiting
Phase Phase 3
Start date September 16, 2022
Completion date February 28, 2027

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02659462 - Cardio Pulmonary Exercise Testing in Patients Post the Fontan Palliation in Comparison With Patients With Repaired Congenital Heart Disease and Healthy Volunteers. N/A
Completed NCT00633815 - Upright Versus Supine Exercise Testing in Fontan-palliated Patients N/A